RDW-CV (%) | Overall (N = 488) | Control (n = 241) | Case (n = 247) | ||||
---|---|---|---|---|---|---|---|
 | Median (IQR) | P | Median (IQR) | P | Median (IQR) | p | |
Study groups |  | 14.5 (2.7) |  | 20.7 (8.3) |  < 0.0001 | ||
Gender | Male | 17.1(8.0) | 0.317 | 14.55 (1.9) | 0.089 | 21.2 (7.50) | 0.056 |
Female | 15.5(6.7) | 14.2 (2.4) | 20.1 (8.80) | ||||
Age |  ≤ 5 Years | 19.0 (7.1) | 0.001 | 15.95 (4.2) | 0.001 | 21.2 (7.10) | 0.138 |
6–12 years | 15.5(8.2) | 14.2 (1.7) | 19.9 (7.90) | ||||
 ≤ 5 Years | 19.0 (7.1) |  < 0.0001 | 15.95 (4.2) |  < 0.0001 | 21.2 (7.10) |  < 0.0001 | |
 ≥ 13 Years | 14.1 (2.8) | 13.7 (1.8) | 16.5 (2.75) | ||||
6–12 Years | 15.5(8.2) |  < 0.0001 | 14.2 (1.7) | 0.347 | 19.9 (7.90) | 0.225 | |
 ≥ 13 Years | 14.1 (2.8) | 13.70 (1.8) | 16.5 (2.75) | ||||
Hb Phenotypes | Hb AA | 14.5 (2.7) | Â | ||||
Hb SS | 25.4 (5.5) |  < 0.0001 | |||||
Hb SS + Hemoglobin F | 20.9 (5.5) |  < 0.0001 | |||||
Hb SS + Beta Thalassemia | 23.3 (7.9) |  < 0.0001 | |||||
Hb AS | 16.4 (6.5) |  < 0.0001 | |||||
Hb AS + Hemoglobin F | 24.2 (7.4) | 0.449 | |||||
Hb AS + Beta Thalassemia | 21.0 (10.5) | 0.791 | |||||
Beta Thalassemia | 18.1 (8.3) | 1.00 |